RNA sequencing and novel machine learning algorithms generate a test that improves lung cancer diagnosis using brushings from the main lung airway SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 22, 2020-- Veracyte, Inc . (Nasdaq: VCYT) today announced the publication of a manuscript detailing
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 19, 2020-- Veracyte, Inc ., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting 2020 show that a genomic smoking index developed for use on samples obtained from the main lung airway can also be detected in nasal
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 14, 2020-- Veracyte, Inc. (Nasdaq: VCYT) announced today that an oral presentation will be given at the CHEST Annual Meeting 2020 reinforcing the foundational technology behind its noninvasive nasal swab test to identify lung cancer risk in
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 7, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that it will release its financial results for the third quarter of 2020 after the close of market on Monday, November 2, 2020 . Company management will host a conference call and webcast to
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 24, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that the Centers for Medicare and Medicaid Services (CMS) has approved new Advanced Diagnostic Laboratory Test (ADLT) status for the Envisia ® Genomic Classifier.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 15, 2020-- Veracyte, Inc . (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie H. Anderson , chairman and chief executive officer, is scheduled to participate in two virtual investor conferences this week: 2020 Cantor
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 14, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that it has promoted Richard T. Kloos , M.D., to executive medical director, overseeing Veracyte’s global medical affairs in all clinical areas addressed by the company’s expanding menu of
PROCURE study will capture insights from 180 European breast cancer specialists, to develop consensus and recommendations SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 11, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today the initiation of a European study that will utilize the Delphi
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 4, 2020-- Veracyte, Inc . (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie H. Anderson , chairman and chief executive officer, is scheduled to participate in two upcoming virtual investor conferences: Baird’s 2020
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 24, 2020-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that it has been awarded a Top Workplaces 2020 honor by the Bay Area News Group for the seventh consecutive year.
The information in our press releases and webcasts should be considered accurate only as of the date of the press release or presentation. We disclaim any obligation to supplement or update the information in these press releases or presentations.
